Sarah Alnami, PharmD Candidate

Medical University of South Carolina

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-60) Evaluation of clinical outcomes in Methicillin-Resistant Staphylococcus aureus bacteremia with earlier vs. later initiation of dual antimicrobial salvage therapy
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET